In a report released on May 8, Sabina Levi from Leader Capital Markets maintained a Buy rating on Teva (TEVA – Research Report), with a price target of ILA9,300.00. The company’s shares closed today at ILA6,070.00.
Teva has an analyst consensus of Hold.
The company has a one-year high of ILA8,431.00 and a one-year low of ILA4,865.00. Currently, Teva has an average volume of 1.89M.
Read More on IL:TEVA:
- Teva price target raised to $22 from $20 at BofA
- Teva Pharmaceuticals: Positioned for Growth with Strategic Cost-Saving Initiatives and New Product Cycle
- Teva reports Q1 EPS 52c, consensus 46c
- Teva sees FY25 EPS $2.45-$2.65, consensus $2.56
- Teva, Alvotech: FDA approves interchangeability for SELARSDI with Stelara
